Dr. Tyler Scott Weaver, MD

Dr. Weaver practices at Gastroenterology South - Oregon City in Oregon City, Oregon.

Dr. Weaver's NPI, 1326467812, was assigned on April 10, 2014. Dr. Weaver graduated from Oregon Health Sciences University School of Medicine in 2014. Dr. Weaver holds Oregon license MD194367.

Dr. Weaver's primary practice is Gastroenterology South - Oregon City, at 1508 Division St, Oregon City, OR 97045 in Clackamas County. The practice phone is (503) 692-3750.

Dr. Weaver's primary practice is Gastroenterology South - Oregon City in Oregon City, Oregon. Dr. Weaver is also affiliated with Providence Willamette Falls Medical Center. The medical group on file is The Oregon Clinic. Dmand AI also links Dr. Weaver to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weaver practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Weaver's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Weaver is licensed in Oregon.

CMS data shows 950 Medicare services from Dr. Weaver across 8 procedure codes in 2024, for 210 Medicare patients. Medicare paid $28,002 for them. Every service was in an office.

CMS counts 210 Medicare patients who saw Dr. Weaver in 2024. The largest group is 65 to 74, with 98 patients. 66% of them have high blood pressure, and 64% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weaver's median patient age at 54, with 53% women.

In 2024, Dr. Weaver wrote 594 Medicare Part D claims for 186 patients. 96% of them were for generic drugs. CMS names the drug for 530 of them, across 15 drugs with 11 or more claims each, at $9,280 in total drug cost. In 2023, CMS named 462 claims across 15 drugs.

Dr. Weaver accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Weaver, published from 2013 to 2017. The most frequent topics are Cochlear Implants, Gait and Graft Rejection. Dr. Weaver has published most often in Laryngoscope. Dr. Weaver's most frequent co-authors are Timothy Everett Hullar, MD, Jordan James Allensworth and Javier David Gonzalez, MD.

CMS Open Payments shows 29 general payments to Dr. Weaver from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Intersect ENT, Inc. paid the most, $1,167.

Dr. Weaver graduated from Oregon Health Sciences University School of Medicine in 2014.